(MedPage Today) -- Blocking RAS pathway not better than other preventive strategies
via No Survival Advantage with ACE Inhibitors in Stable CAD (CME/CE)
by
Showing posts with label No Survival Advantage with ACE Inhibitors in Stable CAD (CME/CE). Show all posts
Showing posts with label No Survival Advantage with ACE Inhibitors in Stable CAD (CME/CE). Show all posts
Thursday, January 19, 2017
Subscribe to:
Posts (Atom)